Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

PF 956980

Known as: PF-956980, PF956980 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Methods of treating vitiligo using JAK/STAT modulating compounds are provided herein. The JAK/STAT modulating compounds may be… Expand
Is this relevant?
2017
2017
PF-956980 has been used previously as a JAK3-selective chemical probe in numerous cell-based experiments. Here, we report that… Expand
Is this relevant?
2016
2016
  • 2016
  • Corpus ID: 207760052
coimmunoprecipitates, they observed an association of both proteins. Pharmacologic inhibition of the JAK/STAT5 signaling pathway… Expand
Is this relevant?
2015
2015
Background CD8+ T-cells are located in the small airways of COPD patients and may contribute to pathophysiology. CD8+ cells… Expand
  • table 1
  • table 2
  • figure 2
  • table 3
  • table 4
Is this relevant?
2013
2013
Janus kinase (JAK) inhibitors have been developed as anti‐inflammatory agents and have demonstrated clinical efficacy in… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Extensive evidence suggests that the malignant cells of chronic lymphocytic leukemia (CLL) patients are in close contact with… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
PF-956980 is a selective inhibitor of JAK3, related in structure to CP-690550, a compound being evaluated in clinical trials for… Expand
  • figure 1
  • table 1
Is this relevant?